You are here
Doctoral theses
Doctoral theses lie within the interests of Cemcat with the aim of promoting research into multiple sclerosis. Most theses are directed by Dr. Xavier Montalban, the Director of Cemcat, but also other members of the centre.
Between 2014 and 2016 more than 10 doctoral theses conducted by Cemcat researchers were presented.
Early predictors of response to interferon treatment in patients with multiple sclerosis
Joaquín Castilló, November 2016
Role of the PRF1, CASP8 and BTG1 genes in multiple sclerosis
Montserrat Camiña, November 2016
Study of pseudo-atrophy in patients with relapsing-remitting multiple sclerosis
Angela Vidal Jordana, May 2016
Study of diagnostic and prognostic clinical, biological and magnetic resonance markers in isolated clinical syndromes
Georgina Arrambide, March 2016
Epidemiology of Multiple Sclerosis in Catalonia
Susana Otero Romero, January 2016
Prognostic clinical markers of clinically isolated syndromes
Raúl Pelayo Vergara, January 2016
Changes in cerebral volume and cerebral metabolites in the initial phases of primary progressive multiple sclerosis. A longitudinal short-term study.
Jaume Sastre Garriga, April 2015
Study of the function of Heat Shock Protein-70 in the pathogeny of multiple sclerosis
María José Mansilla, January 2015
Search for biomarkers associated with conversion to MS in patients with isolated clinical syndromes
Ester Cantó Puig, December 2014
Clinical and magnetic resonance study of cognitive performance in isolated neurological syndromes suggestive of multiple sclerosis
María Jesús Arévalo Navinés, December 2014
Function of the 3A and 7A semaphorins in neuroregeneration and in the regulation of immune response to autoimmune encephalomyelitis
Ana Gutiérrez Franco, December 2014
Involvement of the TLR4 route and the type IIFNS route and monocytes in the clinical response to beta interferon in patients with multiple sclerosis
Marta Fernández Bustamante, December 2014
